Phase II Trial of Continuation Therapy in Advanced NSCLC

Clinical trial NCT03083808 · COMPLETED

Trial details

NCT number

NCT03083808

Sponsor

Greg Durm, MD

Status

COMPLETED

Phase

Phase 2

Study type

INTERVENTIONAL

Start date

2017-03-20

Primary completion

2021-12-14

Enrollment

35

View on ClinicalTrials.gov